Stephen B. Hanauer
Elite in Viral Gastroenteritis

Dr. Stephen B. Hanauer

Gastroenterology
Northwestern Medical Group
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
Offers Telehealth
49 Years of Experience

Elite in Viral Gastroenteritis
Northwestern Medical Group
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Stephen Hanauer is a Gastroenterologist in Chicago, Illinois. Dr. Hanauer has been practicing medicine for over 49 years and is rated as an Elite provider by MediFind in the treatment of Viral Gastroenteritis. His top areas of expertise are Crohn's Disease, Viral Gastroenteritis, Ulcerative Colitis, Colonoscopy, and Endoscopy.

His clinical research consists of co-authoring 242 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 222 articles and participated in 10 clinical trials in the study of Viral Gastroenteritis.

Graduate Institution
University Of Illinois At Chicago College Of Medicine, 1977.0
Residency
University of Chicago
Specialties
Gastroenterology
Licenses
Internal Medicine in IL
Board Certifications
American Board Of Internal Medicine - Gastroenterology (Certified)
Fellowships
University of Chicago
Hospital Affiliations
Northwestern Memorial Hospital
Northwestern Lake Forest Hospital
Northwestern Medicine Central Dupage Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

259 E Erie St Ste 1600, Lavin Family Pavilion, Chicago, IL 60611
Call: 312-695-5620

Additional Areas of Focus

Dr. Hanauer has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Colitis
Crohn's Disease

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
Efficacy and Safety of ALTB-168 in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or Anti-integrin Refractory Ulcerative Colitis: a 26-week, Open-label, Multi-center, Phase II Proof of Principle Trial
Efficacy and Safety of ALTB-168 in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or Anti-integrin Refractory Ulcerative Colitis: a 26-week, Open-label, Multi-center, Phase II Proof of Principle Trial
Enrollment Status: Terminated
Publish Date: January 05, 2024
Intervention Type: Biological
Study Phase: Phase 2
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
Open Label, Randomized, Multicenter, Comparative Effectiveness Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission in Patients With Crohn's Disease
Open Label, Randomized, Multicenter, Comparative Effectiveness Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission in Patients With Crohn's Disease
Enrollment Status: Completed
Publish Date: July 21, 2021
Intervention Type: Other
Study Phase: Not Applicable
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials

242 Total Publications

The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn's disease.
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn's disease.
Journal: Expert review of gastroenterology & hepatology
Published: May 26, 2025
View All 242 Publications
Similar Doctors
Parambir S. Dulai
Elite in Viral Gastroenteritis
Dr. Parambir S. Dulai
Gastroenterology
Elite in Viral Gastroenteritis
Dr. Parambir S. Dulai
Gastroenterology
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
 (0.1 miles away)
312-695-5620
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Parambir Dulai is a Gastroenterologist in Chicago, Illinois. Dr. Dulai has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Viral Gastroenteritis. His top areas of expertise are Viral Gastroenteritis, Ulcerative Colitis, Hemorrhagic Proctocolitis, Endoscopy, and Colonoscopy.

Elite in Viral Gastroenteritis
Dr. Frank Hoentjen
Gastroenterology
Elite in Viral Gastroenteritis
Dr. Frank Hoentjen
Gastroenterology
5841 S Maryland Ave, Room M226(mc4076), 
Chicago, IL 
 (7.4 miles away)
773-702-6073
Languages Spoken:
English

Frank Hoentjen is a Gastroenterologist in Chicago, Illinois. Dr. Hoentjen is rated as a Distinguished provider by MediFind in the treatment of Viral Gastroenteritis. His top areas of expertise are Viral Gastroenteritis, Colitis, Crohn's Disease, Colonoscopy, and Endoscopy.

Russell D. Cohen
Elite in Viral Gastroenteritis
Dr. Russell D. Cohen
Gastroenterology
Elite in Viral Gastroenteritis
Dr. Russell D. Cohen
Gastroenterology

The University Of Chicago

5841 S Maryland Ave, 
Chicago, IL 
 (7.4 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Russell Cohen is a Gastroenterologist in Chicago, Illinois. Dr. Cohen is rated as an Elite provider by MediFind in the treatment of Viral Gastroenteritis. His top areas of expertise are Ulcerative Colitis, Crohn's Disease, Hemorrhagic Proctocolitis, Ileostomy, and Colonoscopy. Dr. Cohen is currently accepting new patients.

VIEW MORE VIRAL GASTROENTERITIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hanauer's expertise for a condition
ConditionClose
  • Elite
  • Colitis
    Dr. Hanauer is
    Elite
    . Learn about Colitis.
    See more Colitis experts
  • Crohn's Disease
    Dr. Hanauer is
    Elite
    . Learn about Crohn's Disease.
    See more Crohn's Disease experts
  • Hemorrhagic Proctocolitis
    Dr. Hanauer is
    Elite
    . Learn about Hemorrhagic Proctocolitis.
    See more Hemorrhagic Proctocolitis experts
  • Ulcerative Colitis
    Dr. Hanauer is
    Elite
    . Learn about Ulcerative Colitis.
    See more Ulcerative Colitis experts
  • Viral Gastroenteritis
    Dr. Hanauer is
    Elite
    . Learn about Viral Gastroenteritis.
    See more Viral Gastroenteritis experts
    • Advanced
    • Colonoscopy
      Dr. Hanauer is
      Advanced
      . Learn about Colonoscopy.
      See more Colonoscopy experts
    • Endoscopy
      Dr. Hanauer is
      Advanced
      . Learn about Endoscopy.
      See more Endoscopy experts
    • Irritable Bowel Syndrome (IBS)
      Dr. Hanauer is
      Advanced
      . Learn about Irritable Bowel Syndrome (IBS).
      See more Irritable Bowel Syndrome (IBS) experts
    • Experienced
    • Anemia
      Dr. Hanauer is
      Experienced
      . Learn about Anemia.
      See more Anemia experts
    • Collagenous Colitis
      Dr. Hanauer is
      Experienced
      . Learn about Collagenous Colitis.
      See more Collagenous Colitis experts
    • Colorectal Cancer
      Dr. Hanauer is
      Experienced
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Colorectal Polyps
      Dr. Hanauer is
      Experienced
      . Learn about Colorectal Polyps.
      See more Colorectal Polyps experts
    • Diarrhea
      Dr. Hanauer is
      Experienced
      . Learn about Diarrhea.
      See more Diarrhea experts
    • Eosinophilic Colitis
      Dr. Hanauer is
      Experienced
      . Learn about Eosinophilic Colitis.
      See more Eosinophilic Colitis experts
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.